Impact of Dolutegravir-based Regimen on Tolerance and Virologic Suppression, Compared to Non-dolutegravir Regimen among PLHIV in Southern Senegal
Kalilou Diallo, Dame Mbengue, Habibou SARR, Abdou Badiane, Khadidiatou Diallo, Mame Ngoné Coly, Ludmillie Annie Badji, Bruce Shinga Wembulua, Khardiata Diallo, Ansoumana Diatta & Noel Magloire Manga · Asian Journal of Research in Infectious Diseases · 2024
Background: In 2020, Senegal began a transition to a Dolutgravir-based treatment as a first-line regimen in all new ART initiators in accordance with WHO recommendations. Aims: To determine the virological suppression and the tolerance on patients under a dolutegravir-based regim...
Open access
Research Article
10.9734/ajrid/2024/v15i3336